Book Cover
Home  |   Healthcare   |  Biliary Stent Market

Biliary Stent Market Size, Share, Growth, and Industry Analysis, By Type (Metal Stents, Polymer Stents), By Application (Hospital, Medical Center), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Biliary Stent Market Overview

The global Biliary Stent Market is set to grow from USD 409.1 Million in 2026 to USD 618.44 Million by 2035, exhibiting a CAGR of 4.7% over the forecast period 2026-2035.

The Biliary Stent Market is developing as healthcare providers expand minimally invasive treatment for bile duct obstruction, benign strictures, and malignant hepatobiliary conditions. Metal Stents represent approximately 56% of the market in the reference product classification, reflecting their importance in maintaining biliary drainage during selected procedures. Biliary stents are small tubular devices placed within the bile duct to restore or maintain bile flow when normal drainage becomes obstructed. Clinicians commonly insert these devices using endoscopic retrograde cholangiopancreatography, while selected patients require alternative image-guided approaches. Product selection depends on obstruction characteristics, anticipated treatment duration, removability, and clinical requirements. 

The United States represents an important national market for biliary stents through established gastroenterology services, specialized hospitals, and extensive interventional imaging infrastructure. North America accounts for approximately 43% of global market activity when the reference regional figure is rounded to a whole number. American hospitals increasingly use therapeutic endoscopy to manage bile duct obstruction associated with malignant and benign conditions. Advanced medical centers provide specialized services involving endoscopic visualization, fluoroscopic guidance, and biliary drainage procedures. Clinical decisions require consideration of patient anatomy and the expected duration of drainage. Hospitals increasingly emphasize appropriate device selection and monitoring for complications. 

Global Biliary Stent Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Increasing demand for minimally invasive biliary drainage supports market development, with approximately 45% of reported stenting demand associated with malignant biliary obstruction and related clinical management requirements.
  • Major Market Restraint: Stent blockage and repeat intervention remain important limitations, with plastic biliary stent occlusion reported in approximately 25% of cases within selected six-month clinical observation periods.
  • Emerging Trends: Covered metal stents and advanced deployment technologies are influencing treatment choices, with approximately 20% of recent product development activity in the reference assessment emphasizing coated biliary stent designs.
  • Regional Leadership: North America leads the Biliary Stent Market with approximately 43% share, supported by established therapeutic endoscopy services, specialized hospitals, and substantial access to advanced gastrointestinal procedures.
  • Competitive Landscape: Medtronic holds approximately 17% of the global Biliary Stent Market according to a reported market assessment, while Karl Storz strengthened its position in complementary biliary imaging technologies through regulatory clearance in February 2026.
  • Market Segmentation: Metal Stents leads the supplied product classification with approximately 56% share, while Hospital dominates the application category through specialized endoscopy infrastructure and management of complex biliary conditions.
  • Recent Development: Karl Storz obtained clearance for its RUBINA imaging technology in February 2026, supporting visualization of 3 major extrahepatic bile ducts during suitable minimally invasive procedures.

The Biliary Stent Market is increasingly influenced by improvements in self-expanding metal stents, polymer materials, and controlled endoscopic deployment technologies. Approximately 20% of recent stent development activity in the reference assessment involved coated designs, demonstrating continuing interest in reducing obstruction and improving device performance. Covered metal stents provide a physical barrier between the stent lumen and surrounding tissue, although their clinical suitability depends on the underlying condition. 

Improved procedural imaging and minimally invasive treatment planning represent additional trends affecting biliary stent utilization. The reference assessment indicates that approximately 60% of biliary interventions use endoscopic approaches, although procedure distribution varies across clinical settings. Endoscopic retrograde cholangiopancreatography remains an important technique because it combines imaging with therapeutic access to the biliary system. Fluoroscopy assists clinicians during guidewire manipulation, stricture assessment, and device placement. 

Biliary Stent Market Dynamics

Driver

"Increasing biliary disease management strengthens demand for minimally invasive drainage."

Growing demand for treatment of malignant and benign biliary obstruction represents a primary driver of the Biliary Stent Market. Approximately 45% of reported stenting demand in the reference clinical assessment is associated with malignant biliary obstruction. Patients may require drainage when tumors, inflammatory conditions, or postoperative complications interfere with normal bile flow. Endoscopic stenting can provide a less invasive treatment approach than open surgery for appropriately selected patients. Clinicians assess obstruction location, anatomy, infection risk, and treatment objectives before intervention. 

Increasing availability of therapeutic endoscopy creates additional demand for biliary devices. Approximately 70% of stent procedures in the reference assessment are performed in hospitals with specialized clinical infrastructure. Such facilities commonly provide endoscopy equipment, imaging support, anesthesia services, and management of procedural complications. Biliary stenting is increasingly integrated into multidisciplinary care involving gastroenterologists, surgeons, radiologists, and oncology teams. 

Restraint

"Device occlusion and repeat procedures limit treatment efficiency."

Stent blockage remains a significant limitation affecting biliary drainage procedures. Plastic stent occlusion has been reported in approximately 25% of cases over selected six-month observation periods, although individual risk depends on device characteristics and clinical circumstances. Blockage may result from biliary sludge, bacterial biofilm, or progression of the underlying disease. Patients can require additional assessment and replacement when drainage becomes inadequate. 

Stent migration and inappropriate device positioning create additional concerns. Plastic stent migration rates of approximately 10% have been described in selected clinical assessments, with substantial variation according to the indication and device design. Migration can compromise drainage or require additional endoscopic management. Covered metal stents also carry migration risks, particularly in certain benign conditions. Manufacturers develop different anchoring features and deployment mechanisms to address these problems. 

Opportunity

"Advanced materials and accessible endoscopy create new treatment opportunities."

Development of improved biliary stent materials represents an important opportunity for medical device manufacturers. Approximately 8% of product introductions in the reference assessment involved biodegradable or emerging polymer designs. Biodegradable devices are being investigated for selected situations where eventual material breakdown could reduce the need for removal. However, these technologies require evidence demonstrating predictable degradation, safe drainage, and acceptable clinical outcomes. 

Improving access to specialized biliary procedures creates additional opportunities within healthcare infrastructure. Medical Center represents approximately 27% of application demand in the reference market assessment, indicating a substantial role for facilities outside large hospitals. Appropriate outpatient treatment can reduce dependence on inpatient resources when patients meet clinical suitability requirements. Medical centers require specialist expertise, suitable imaging capabilities, and established emergency referral arrangements. 

Challenge

"Clinical complexity and limited specialist access challenge wider adoption."

Managing complex biliary obstruction requires substantial clinical expertise and careful device selection. Approximately 30% of specialist physicians in the reference assessment identified limited long-term evidence as a consideration when evaluating emerging stent designs. New materials and coatings may demonstrate promising early performance without establishing consistent outcomes across different patient groups. Clinical conditions vary according to obstruction cause, location, and disease progression. A device suitable for malignant obstruction may not be the preferred option for a temporary benign stricture. 

Unequal access to therapeutic endoscopy also limits market expansion. The reference assessment reports that approximately 30% of selected secondary hospitals in some emerging healthcare systems have appropriate endoscopic retrograde cholangiopancreatography facilities. Limited imaging equipment, specialist availability, and procedural support can restrict access to biliary drainage. Patients in underserved areas may require referral to larger hospitals, introducing additional treatment delays. Medical centers also need suitable sterilization arrangements and reliable device supply. 

Biliary Stent Market Segmentation 

Global Biliary Stent Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

Metal Stents: Metal Stents represent the leading product category within the Biliary Stent Market because of their importance in treating selected biliary obstructions. The segment accounts for approximately 56% of global demand when the reference product figures are rounded to whole numbers. These devices commonly use self-expanding metallic structures designed to maintain an open drainage pathway. Covered and uncovered configurations have different clinical characteristics. 

Polymer Stents: Polymer Stents provide an established option for temporary biliary drainage and situations requiring planned exchange or removal. The segment accounts for approximately 44% of global demand when the reference classification is normalized to the supplied product categories. These devices are commonly manufactured from medical-grade plastic materials and offered in different lengths and diameters. Clinicians frequently use polymer stents for selected benign strictures and temporary drainage needs. 

By Applications

Hospital: Hospital represents the largest application category through extensive management of complex gastrointestinal and hepatobiliary conditions. The segment accounts for approximately 73% of global demand when the reference application distribution is rounded and normalized. Hospitals typically provide therapeutic endoscopy, fluoroscopic imaging, anesthesia support, and multidisciplinary clinical services. These capabilities are important when patients have severe obstruction, infection, or additional medical conditions. 

Medical Center: Medical Center includes specialist endoscopy facilities and outpatient treatment settings providing appropriately selected biliary procedures. The segment accounts for approximately 27% of global demand in the normalized reference application classification. Such facilities can offer treatment to patients whose clinical condition does not require extensive hospital-based support. Appropriate procedural equipment, experienced specialists, and reliable referral arrangements remain essential.  

Biliary Stent Market Regional Outlook

Global Biliary Stent Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America leads the Biliary Stent Market through established healthcare infrastructure, experienced therapeutic endoscopy specialists, and extensive use of advanced medical devices. The region accounts for approximately 43% of global demand based on the rounded reference geographic figure. The United States maintains a substantial role through tertiary hospitals, cancer treatment services, and specialized gastrointestinal care. Canada contributes through established hospital systems and interventional endoscopy facilities. 

Europe

Europe represents a major Biliary Stent Market region through extensive gastroenterology services, advanced healthcare systems, and established medical device regulation. The region accounts for approximately 27% of global demand within the reference geographic range. Germany, France, the United Kingdom, Italy, and Spain maintain specialist centers treating bile duct obstruction and related conditions. European clinicians increasingly emphasize evidence-based device selection and appropriate procedural follow-up. 

Asia-Pacific

Asia-Pacific represents an important Biliary Stent Market region through expanding specialist healthcare infrastructure and growing access to therapeutic endoscopy. The reference assessment places its global share within a range extending from approximately 20% to 28%, depending on the market definition used. China, Japan, India, South Korea, and Australia maintain different levels of access to advanced biliary procedures. Japan has established specialist endoscopy capabilities, while other markets continue expanding regional treatment infrastructure. 

Middle East and Africa

Middle East and Africa represents developing demand for biliary stents through hospital modernization and expansion of specialist gastrointestinal services. The reference market assessment places this region within an approximate 4% to 6% global share range. Gulf healthcare systems increasingly invest in advanced hospital equipment, while specialist facilities in South Africa and other countries provide therapeutic endoscopy services. Access remains uneven between urban hospitals and smaller regional facilities. 

Rest of the World

Rest of the World includes Latin America and additional markets not independently separated in the reference geographic analysis. The supplied regional ranges do not establish a comparable positive percentage for this category, preventing an accurate five-region allocation without further data. Brazil, Mexico, Argentina, and neighboring countries maintain hospital and medical center services addressing biliary obstruction. Access to therapeutic endoscopy varies between major cities and underserved areas. Healthcare providers increasingly evaluate suitable devices and specialist training requirements. 

List of Top Biliary Stent Market Companies

  • Brainlab
  • GE Healthcare
  • Medtronic
  • Stryker
  • Blue Belt Technologies
  • MAKO
  • Claron Technology
  • Karl Storz
  • Fiagon
  • Medacta International
  • Micromar
  • OrthAlign
  • Scopis
  • Zimmer

Top Two Companies with Highest Market Share

  • Medtronic: Medtronic holds approximately 17% of the global Biliary Stent Market according to a published market research assessment.
  • Karl Storz: Karl Storz holds approximately 2% of the broader ERCP equipment market, but its specific global biliary stent market share has not been independently verified.

Investment Analysis and Opportunities

Investment opportunities in the Biliary Stent Market increasingly concentrate on reliable drainage technologies, controlled deployment systems, and clinical evidence supporting improved device performance. Approximately 56% of demand in the normalized product classification is associated with Metal Stents, indicating substantial use of devices intended for selected longer-duration drainage requirements. Manufacturers increasingly investigate covering materials and deployment mechanisms to address migration and obstruction. 

Expansion of therapeutic endoscopy services creates additional opportunities for healthcare infrastructure investment. Medical Center represents approximately 27% of application demand in the reference classification, demonstrating the importance of specialized facilities beyond major hospitals. Investments in imaging systems, clinical training, and procedural support can improve access to appropriate biliary interventions. Hospitals require reliable endoscopy equipment and suitable medical device inventories. 

New Product Development

New product development in the Biliary Stent Market increasingly emphasizes controlled deployment, improved drainage patency, and reduction of repeat procedures. The reference assessment identifies approximately 8% of new design activity involving biodegradable stent concepts, although commercial adoption remains dependent on clinical validation. Advanced Polymer Stents are being investigated for temporary treatment situations where eventual degradation could offer practical advantages. Metal Stents continue evolving through different covering materials and delivery-system characteristics. 

Imaging technology represents a complementary area of innovation supporting biliary intervention. Karl Storz obtained regulatory clearance in February 2026 for an indocyanine green imaging system with RUBINA technology capable of visualizing 3 major extrahepatic bile ducts in appropriate surgical procedures. The system assists anatomical visualization but is not itself a biliary stent. GE Healthcare also continued expanding interventional imaging capabilities during 2026, supporting procedural environments in which accurate anatomical information is important. 

Five Recent Developments

  • February 2026 – Karl Storz Receives Advanced Biliary Visualization Clearance: Karl Storz received regulatory clearance for its RUBINA imaging system on February 26, enabling visualization of 3 major extrahepatic bile ducts under specified clinical conditions. The technology supports surgical imaging rather than functioning as an implanted biliary stent.
  • May 2026 – Karl Storz Introduces Next Generation Operating Rooms: Karl Storz presented its next-generation integrated operating room technologies on May 15, supporting modern minimally invasive procedural environments. These capabilities may complement specialist gastrointestinal services but do not constitute a biliary stent product launch.
  • June 2026 – Karl Storz Expands European Surgical Integration: Karl Storz announced the European launch of its next-generation integrated operating room solution on June 25. The development strengthens digital procedural infrastructure relevant to specialized endoscopy and other surgical applications.
  • September 2026 – Medtronic Receives Clearance For Peripheral Stent System: Medtronic received regulatory clearance on September 17 for its Protégé EverFlex self-expanding peripheral stent system. The device is intended for peripheral vascular use and must not be represented as a new biliary stent despite its broader regulatory classification.
  • November 2026 – GE Healthcare Introduces Advanced Interventional Imaging Platform: GE Healthcare announced Allia Celeo on November 1, introducing a ceiling-mounted interventional imaging system designed to support procedural workflow. The platform is a complementary imaging technology and not a dedicated biliary stent device.

Future Outlook

The Biliary Stent Market is expected to benefit from continuing demand for minimally invasive treatment of bile duct obstruction and ongoing improvement in therapeutic endoscopy. Metal Stents will remain important for selected conditions requiring longer drainage duration, while Polymer Stents will continue supporting temporary treatment and planned exchange. Hospitals will retain a major role because complex patients frequently require specialized imaging and multidisciplinary clinical support. 

Regional development will remain influenced by the availability of specialist gastroenterology services, healthcare infrastructure, and appropriate medical device reimbursement. North America will continue supporting advanced treatment through established hospitals and research capabilities. Europe will maintain substantial activity through specialist care and clinical evaluation, while Asia-Pacific will offer opportunities through expanding procedural capacity. 

Biliary Stent Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 409.1 Million in 2026

Market Size Value By

USD 618.44 Million by 2035

Growth Rate

CAGR of 4.7% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Metal Stents
  • Polymer Stents

By Application :

  • Hospital
  • Medical Center

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Biliary Stent Market is expected to reach USD 618.44 Million by 2035.

The Biliary Stent Market is expected to exhibit a CAGR of 4.7% by 2035.

Brainlab, GE Healthcare, Medtronic, Stryker, Blue Belt Technologies, MAKO, Claron Technology, Karl Storz, Fiagon, Medacta International, Micromar, OrthAlign, Scopis, Zimmer

In 2026, the Biliary Stent Market value will reach at USD 409.1 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified